appn-202203312022Q1FALSE0001441683--12-31P1YP1YP1Y00014416832022-01-012022-03-310001441683us-gaap:CommonClassAMember2022-05-02xbrli:shares0001441683us-gaap:CommonClassBMember2022-05-0200014416832022-03-31iso4217:USD00014416832021-12-310001441683us-gaap:CommonClassAMember2022-03-31iso4217:USDxbrli:shares0001441683us-gaap:CommonClassAMember2021-12-310001441683us-gaap:CommonClassBMember2022-03-310001441683us-gaap:CommonClassBMember2021-12-310001441683appn:SubscriptionsSoftwareAndSupportMember2022-01-012022-03-310001441683appn:SubscriptionsSoftwareAndSupportMember2021-01-012021-03-310001441683appn:ProfessionalServicesMember2022-01-012022-03-310001441683appn:ProfessionalServicesMember2021-01-012021-03-3100014416832021-01-012021-03-310001441683us-gaap:CommonStockMember2021-12-310001441683us-gaap:AdditionalPaidInCapitalMember2021-12-310001441683us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001441683us-gaap:RetainedEarningsMember2021-12-310001441683us-gaap:RetainedEarningsMember2022-01-012022-03-310001441683us-gaap:CommonStockMember2022-01-012022-03-310001441683us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001441683us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310001441683us-gaap:CommonStockMember2022-03-310001441683us-gaap:AdditionalPaidInCapitalMember2022-03-310001441683us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310001441683us-gaap:RetainedEarningsMember2022-03-310001441683us-gaap:CommonStockMember2020-12-310001441683us-gaap:AdditionalPaidInCapitalMember2020-12-310001441683us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001441683us-gaap:RetainedEarningsMember2020-12-3100014416832020-12-310001441683us-gaap:RetainedEarningsMember2021-01-012021-03-310001441683us-gaap:CommonStockMember2021-01-012021-03-310001441683us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310001441683us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-03-310001441683us-gaap:CommonStockMember2021-03-310001441683us-gaap:AdditionalPaidInCapitalMember2021-03-310001441683us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310001441683us-gaap:RetainedEarningsMember2021-03-3100014416832021-03-310001441683appn:GovernmentAgenciesMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-31xbrli:pure0001441683appn:GovernmentAgenciesMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-01-012021-03-31appn:agency0001441683appn:FederalGovernmentAgenciesMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310001441683appn:FederalGovernmentAgenciesMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-01-012021-03-310001441683appn:ForeignCustomersMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310001441683appn:ForeignCustomersMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2021-01-012021-03-310001441683appn:PeriodOneMember2022-01-012022-03-310001441683appn:PeriodTwoMember2022-01-012022-03-310001441683us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2022-01-012022-03-310001441683us-gaap:ComputerEquipmentMember2022-01-012022-03-310001441683us-gaap:EquipmentMember2022-01-012022-03-310001441683us-gaap:FurnitureAndFixturesMember2022-01-012022-03-31appn:reporting_unit0001441683appn:SaaSSubscriptionsMember2022-01-012022-03-310001441683appn:SaaSSubscriptionsMember2021-01-012021-03-310001441683appn:TermLicenseSubscriptionsMember2022-01-012022-03-310001441683appn:TermLicenseSubscriptionsMember2021-01-012021-03-310001441683appn:MaintenanceAndSupportMember2022-01-012022-03-310001441683appn:MaintenanceAndSupportMember2021-01-012021-03-310001441683srt:MinimumMember2022-01-012022-03-310001441683srt:MaximumMember2022-01-012022-03-3100014416832022-04-012022-03-310001441683srt:MinimumMember2022-03-310001441683srt:MaximumMember2022-03-3100014416832018-04-30utr:sqft00014416832019-02-2800014416832020-01-3100014416832020-07-0100014416832021-11-30appn:office0001441683appn:OccupancyCommencingOnSeptember12022Member2021-11-300001441683appn:OccupancyCommencingOnMay12023Member2021-11-3000014416832021-11-012021-11-300001441683appn:LanaLabsGMBHMember2021-08-310001441683appn:LanaLabsGMBHMember2021-08-012021-08-310001441683us-gaap:DevelopedTechnologyRightsMemberappn:LanaLabsGMBHMember2021-08-310001441683appn:LanaLabsGMBHMemberus-gaap:CustomerRelationshipsMember2021-08-310001441683appn:LanaLabsGMBHMember2021-08-012022-03-3100014416832021-01-012021-12-310001441683us-gaap:DevelopedTechnologyRightsMember2022-03-310001441683us-gaap:DevelopedTechnologyRightsMember2021-12-310001441683appn:CustomerRelationshipsNonRoboticProcessAutomationRPASoftwareMember2022-03-310001441683appn:CustomerRelationshipsNonRoboticProcessAutomationRPASoftwareMember2021-12-310001441683appn:CustomerRelationshipsRoboticProcessAutomationRPASoftwareMember2022-03-310001441683appn:CustomerRelationshipsRoboticProcessAutomationRPASoftwareMember2021-12-310001441683us-gaap:DevelopedTechnologyRightsMember2022-01-012022-03-310001441683appn:CustomerRelationshipsNonRoboticProcessAutomationRPASoftwareMember2022-01-012022-03-310001441683appn:CustomerRelationshipsRoboticProcessAutomationRPASoftwareMember2022-01-012022-03-310001441683us-gaap:LeaseholdImprovementsMember2022-03-310001441683us-gaap:LeaseholdImprovementsMember2021-12-310001441683us-gaap:FurnitureAndFixturesMember2022-03-310001441683us-gaap:FurnitureAndFixturesMember2021-12-310001441683us-gaap:ComputerEquipmentMember2022-03-310001441683us-gaap:ComputerEquipmentMember2021-12-310001441683us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2022-03-310001441683us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2021-12-310001441683us-gaap:EquipmentMember2022-03-310001441683us-gaap:EquipmentMember2021-12-310001441683us-gaap:RevolvingCreditFacilityMember2017-11-300001441683us-gaap:PrimeRateMembersrt:MinimumMember2017-11-012017-11-300001441683us-gaap:PrimeRateMembersrt:MaximumMember2017-11-012017-11-300001441683srt:MinimumMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2017-11-012017-11-300001441683srt:MaximumMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2017-11-012017-11-300001441683srt:MaximumMember2017-11-012017-11-300001441683srt:MinimumMember2017-11-012017-11-300001441683us-gaap:RevolvingCreditFacilityMember2022-03-310001441683srt:MinimumMembersrt:SubsidiariesMember2022-01-012022-03-310001441683srt:MaximumMembersrt:SubsidiariesMember2022-01-012022-03-310001441683us-gaap:CommonClassAMemberappn:TwoThousandSeventeenEquityIncentivePlanMember2017-05-310001441683appn:TwoThousandSevenStockOptionPlanMember2017-05-310001441683us-gaap:CommonClassAMemberappn:TwoThousandSeventeenEquityIncentivePlanMember2022-03-310001441683appn:TwoThousandSeventeenEquityIncentivePlanMember2022-03-310001441683srt:ChiefExecutiveOfficerMemberappn:TwoThousandSeventeenEquityIncentivePlanMember2019-05-012019-05-310001441683srt:ChiefExecutiveOfficerMemberappn:TwoThousandSeventeenEquityIncentivePlanMember2019-05-310001441683appn:TwoThousandSeventeenEquityIncentivePlanMember2019-05-012019-05-310001441683srt:ChiefExecutiveOfficerMemberappn:A2019CEOGrantMember2022-01-012022-03-310001441683us-gaap:RestrictedStockUnitsRSUMember2021-12-310001441683us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-03-310001441683us-gaap:RestrictedStockUnitsRSUMember2022-03-310001441683us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-03-310001441683us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-03-310001441683us-gaap:EmployeeStockOptionMember2022-01-012022-03-310001441683us-gaap:EmployeeStockOptionMember2021-01-012021-03-310001441683appn:IssuanceOfCommonStockToDirectorsMember2022-01-012022-03-310001441683appn:IssuanceOfCommonStockToDirectorsMember2021-01-012021-03-310001441683appn:SubscriptionsSoftwareAndSupportMember2022-01-012022-03-310001441683appn:SubscriptionsSoftwareAndSupportMember2021-01-012021-03-310001441683appn:ProfessionalServicesMember2022-01-012022-03-310001441683appn:ProfessionalServicesMember2021-01-012021-03-310001441683us-gaap:SellingAndMarketingExpenseMember2022-01-012022-03-310001441683us-gaap:SellingAndMarketingExpenseMember2021-01-012021-03-310001441683us-gaap:ResearchAndDevelopmentExpenseMember2022-01-012022-03-310001441683us-gaap:ResearchAndDevelopmentExpenseMember2021-01-012021-03-310001441683us-gaap:GeneralAndAdministrativeExpenseMember2022-01-012022-03-310001441683us-gaap:GeneralAndAdministrativeExpenseMember2021-01-012021-03-310001441683us-gaap:CommonClassAMember2022-01-012022-03-31appn:vote0001441683us-gaap:CommonClassBMember2022-01-012022-03-310001441683us-gaap:EmployeeStockOptionMember2022-01-012022-03-310001441683us-gaap:EmployeeStockOptionMember2021-01-012021-03-310001441683us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-03-3100014416832021-07-310001441683country:US2022-01-012022-03-310001441683country:US2021-01-012021-03-310001441683us-gaap:NonUsMember2022-01-012022-03-310001441683us-gaap:NonUsMember2021-01-012021-03-310001441683us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2022-03-310001441683us-gaap:MoneyMarketFundsMemberus-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel1Member2022-03-310001441683us-gaap:ShortTermInvestmentsMemberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2022-03-310001441683appn:LongTermInvestmentsMemberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2022-03-310001441683us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueInputsLevel1Member2022-03-310001441683us-gaap:USTreasurySecuritiesMemberus-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel1Member2022-03-310001441683us-gaap:ShortTermInvestmentsMemberus-gaap:USTreasurySecuritiesMemberus-gaap:FairValueInputsLevel1Member2022-03-310001441683appn:LongTermInvestmentsMemberus-gaap:USTreasurySecuritiesMemberus-gaap:FairValueInputsLevel1Member2022-03-310001441683us-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel2Member2022-03-310001441683us-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CashAndCashEquivalentsMember2022-03-310001441683us-gaap:ShortTermInvestmentsMemberus-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel2Member2022-03-310001441683appn:LongTermInvestmentsMemberus-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel2Member2022-03-310001441683us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2022-03-310001441683us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CashAndCashEquivalentsMember2022-03-310001441683us-gaap:ShortTermInvestmentsMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2022-03-310001441683us-gaap:CorporateDebtSecuritiesMemberappn:LongTermInvestmentsMemberus-gaap:FairValueInputsLevel2Member2022-03-310001441683us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Member2022-03-310001441683us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CashAndCashEquivalentsMember2022-03-310001441683us-gaap:ShortTermInvestmentsMemberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Member2022-03-310001441683appn:LongTermInvestmentsMemberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Member2022-03-310001441683us-gaap:CashAndCashEquivalentsMember2022-03-310001441683us-gaap:ShortTermInvestmentsMember2022-03-310001441683appn:LongTermInvestmentsMember2022-03-310001441683us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2021-12-310001441683us-gaap:MoneyMarketFundsMemberus-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel1Member2021-12-310001441683us-gaap:ShortTermInvestmentsMemberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2021-12-310001441683appn:LongTermInvestmentsMemberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2021-12-310001441683us-gaap:USTreasuryBondSecuritiesMemberus-gaap:FairValueInputsLevel1Member2021-12-310001441683us-gaap:USTreasuryBondSecuritiesMemberus-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel1Member2021-12-310001441683us-gaap:ShortTermInvestmentsMemberus-gaap:USTreasuryBondSecuritiesMemberus-gaap:FairValueInputsLevel1Member2021-12-310001441683us-gaap:USTreasuryBondSecuritiesMemberappn:LongTermInvestmentsMemberus-gaap:FairValueInputsLevel1Member2021-12-310001441683us-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel2Member2021-12-310001441683us-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CashAndCashEquivalentsMember2021-12-310001441683us-gaap:ShortTermInvestmentsMemberus-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel2Member2021-12-310001441683appn:LongTermInvestmentsMemberus-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel2Member2021-12-310001441683us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2021-12-310001441683us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CashAndCashEquivalentsMember2021-12-310001441683us-gaap:ShortTermInvestmentsMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2021-12-310001441683us-gaap:CorporateDebtSecuritiesMemberappn:LongTermInvestmentsMemberus-gaap:FairValueInputsLevel2Member2021-12-310001441683us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Member2021-12-310001441683us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CashAndCashEquivalentsMember2021-12-310001441683us-gaap:ShortTermInvestmentsMemberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Member2021-12-310001441683appn:LongTermInvestmentsMemberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Member2021-12-310001441683us-gaap:CashAndCashEquivalentsMember2021-12-310001441683us-gaap:ShortTermInvestmentsMember2021-12-310001441683appn:LongTermInvestmentsMember2021-12-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-Q
(Mark One) | | | | | |
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended March 31, 2022
OR | | | | | |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number: 001-38098
APPIAN CORPORATION
(Exact Name of Registrant as Specified in its Charter)
| | | | | | | | |
Delaware | | 54-1956084 |
(State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification No.) |
| | |
7950 Jones Branch Drive McLean, VA | | 22102 |
(Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code: (703) 442-8844
Securities registered pursuant to Section 12(b) of the Act: | | | | | | | | |
Title of each class | Trading symbol | Name of each exchange on which registered |
Class A Common Stock | APPN | The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| | | | | | | | | | | | | | | | | | | | |
Large accelerated filer | | ☒ | | Accelerated filer | | ☐ |
Non-accelerated filer | | ☐ | | Small reporting company | | ☐ |
| | | | Emerging growth company | | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of May 2, 2022, there were 40,850,302 shares of the registrant’s Class A common stock and 31,497,796 shares of the registrant’s Class B common stock, each with a par value of $0.0001 per share, outstanding.
Table of Contents
| | | | | | | | |
| | Page |
PART I. | | |
Item 1. | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Item 2. | | |
Item 3. | | |
Item 4. | | |
| | |
PART II. | | |
Item 1. | | |
Item 1A. | | |
Item 2. | | |
Item 3. | | |
Item 4. | | |
Item 5. | | |
Item 6. | | |
| |
PART I—FINANCIAL INFORMATION
Item 1. FINANCIAL STATEMENTS
APPIAN CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share data)
| | | | | | | | | | | |
| As of |
| March 31, 2022 | | December 31, 2021 |
| (unaudited) | | |
Assets | | | |
Current assets | | | |
Cash and cash equivalents | $ | 106,795 | | | $ | 100,796 | |
Short-term investments and marketable securities | 53,438 | | | 55,179 | |
Accounts receivable, net of allowance of $1,402 and $1,400 as of March 31, 2022 and December 31, 2021, respectively | 121,630 | | | 130,049 | |
Deferred commissions, current | 25,670 | | | 24,668 | |
Prepaid expenses and other current assets | 30,354 | | | 26,781 | |
Restricted cash, current | 776 | | | 791 | |
Total current assets | 338,663 | | | 338,264 | |
Property and equipment, net of accumulated depreciation of $15,473 and $14,106 as of March 31, 2022 and December 31, 2021, respectively | 38,526 | | | 36,913 | |
Long-term investments | 8,184 | | | 12,044 | |
Goodwill | 27,271 | | | 27,795 | |
Intangible assets, net of accumulated amortization of $1,630 and $1,260 as of March 31, 2022 and December 31, 2021, respectively | 6,615 | | | 7,144 | |
Operating right-of-use assets | 27,556 | | | 27,897 | |
Deferred commissions, net of current portion | 49,398 | | | 49,017 | |
Deferred tax assets | 1,992 | | | 1,025 | |
Restricted cash, net of current portion | 2,328 | | | 2,373 | |
Other assets | 1,980 | | | 2,047 | |
Total assets | $ | 502,513 | | | $ | 504,519 | |
Liabilities and Stockholders’ Equity | | | |
Current liabilities | | | |
Accounts payable | $ | 4,476 | | | $ | 5,766 | |
Accrued expenses | 18,654 | | | 15,483 | |
Accrued compensation and related benefits | 27,834 | | | 35,126 | |
Deferred revenue, current | 146,227 | | | 150,169 | |
Operating lease liabilities, current | 8,135 | | | 8,110 | |
Other current liabilities | 1,104 | | | 1,067 | |
Total current liabilities | 206,430 | | | 215,721 | |
Operating lease liabilities, net of current portion | 47,964 | | | 48,784 | |
Deferred revenue, net of current portion | 1,888 | | | 2,430 | |
Deferred tax liabilities | 98 | | | 209 | |
Other non-current liabilities | 3,377 | | | 3,458 | |
Total liabilities | 259,757 | | | 270,602 | |
Stockholders’ equity | | | |
Class A common stock—par value $0.0001; 500,000,000 shares authorized and 40,829,564 shares issued and outstanding as of March 31, 2022; 500,000,000 shares authorized and 39,964,298 shares issued and outstanding as of December 31, 2021 | 4 | | | 4 | |
Class B common stock—par value $0.0001; 100,000,000 shares authorized and 31,497,796 shares issued and outstanding as of March 31, 2022; 100,000,000 shares authorized and 31,497,796 shares issued and outstanding as of December 31, 2021 | 3 | | | 3 | |
Additional paid-in capital | 528,475 | | | 497,128 | |
Accumulated other comprehensive loss | (5,041) | | | (5,687) | |
Accumulated deficit | (280,685) | | | (257,531) | |
Total stockholders’ equity | 242,756 | | | 233,917 | |
Total liabilities and stockholders’ equity | $ | 502,513 | | | $ | 504,519 | |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
APPIAN CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited, in thousands, except share and per share data)
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
| 2022 | | 2021 | | | | |
Revenue | | | | | | | |
Subscriptions | $ | 83,720 | | | $ | 63,766 | | | | | |
Professional services | 30,546 | | | 25,089 | | | | | |
Total revenue | 114,266 | | | 88,855 | | | | | |
Cost of revenue | | | | | | | |
Subscriptions | 8,206 | | | 5,854 | | | | | |
Professional services | 22,710 | | | 17,675 | | | | | |
Total cost of revenue | 30,916 | | | 23,529 | | | | | |
Gross profit | 83,350 | | | 65,326 | | | | | |
Operating expenses | | | | | | | |
Sales and marketing | 45,916 | | | 35,984 | | | | | |
Research and development | 29,839 | | | 20,690 | | | | | |
General and administrative | 31,461 | | | 19,142 | | | | | |
Total operating expenses | 107,216 | | | 75,816 | | | | | |
Operating loss | (23,866) | | | (10,490) | | | | | |
Other expense | | | | | | | |
Other expense, net | 787 | | | 2,893 | | | | | |
Interest expense | 74 | | | 81 | | | | | |
Total other expense | 861 | | | 2,974 | | | | | |
Loss before income taxes | (24,727) | | | (13,464) | | | | | |
Income tax (benefit) expense | (1,573) | | | 123 | | | | | |
Net loss | $ | (23,154) | | | $ | (13,587) | | | | | |
Net loss per share: | | | | | | | |
Basic and diluted | $ | (0.32) | | | $ | (0.19) | | | | | |
Weighted average common shares outstanding: | | | | | | | |
Basic and diluted | 72,216,870 | | | 70,730,235 | | | | | |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
APPIAN CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(unaudited, in thousands)
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
| 2022 | | 2021 | | | | |
Net loss | $ | (23,154) | | | $ | (13,587) | | | | | |
Comprehensive income, net of income taxes | | | | | | | |
Foreign currency translation adjustment | 757 | | | 4,015 | | | | | |
Unrealized (losses) gains on available-for-sale securities | (111) | | | 8 | | | | | |
Total other comprehensive loss, net of income taxes | $ | (22,508) | | | $ | (9,564) | | | | | |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
APPIAN CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY
(unaudited, in thousands, except share data)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | Accumulated Other Comprehensive (Loss) Income | | | | Total Stockholders' Equity |
| Common Stock | | Additional Paid-In Capital | | | Accumulated Deficit | |
| Shares | | Amount | | | | |
Balance, January 1, 2022 | 71,462,094 | | | $ | 7 | | | $ | 497,128 | | | $ | (5,687) | | | $ | (257,531) | | | $ | 233,917 | |
Net loss | — | | | — | | | — | | | — | | | (23,154) | | | (23,154) | |
Issuance of common stock to directors | 2,395 | | | — | | | — | | | — | | | — | | | — | |
Vesting of restricted stock units | 47,038 | | | — | | | — | | | — | | | — | | | — | |
Exercise of stock options | 815,833 | | | — | | | 24,404 | | | — | | | — | | | 24,404 | |
Stock-based compensation expense | — | | | — | | | 6,943 | | | — | | | — | | | 6,943 | |
Other comprehensive income | — | | | — | | | — | | | 646 | | | — | | | 646 | |
Balance, March 31, 2022 | 72,327,360 | | | $ | 7 | | | $ | 528,475 | | | $ | (5,041) | | | $ | (280,685) | | | $ | 242,756 | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | |
| | | | | | | |
Balance, January 1, 2021 | 70,679,190 | | | $ | 7 | | | $ | 470,498 | | | $ | (5,010) | | | $ | (168,890) | | | $ | 296,605 | |
Net loss | — | | | — | | | — | | | — | | | (13,587) | | | (13,587) | |
Issuance of common stock to directors | 960 | | | — | | | — | | | — | | | — | | | — | |
Vesting of restricted stock units | 56,326 | | | — | | | — | | | — | | | — | | | — | |
Exercise of stock options | 88,269 | | | — | | | 625 | | | — | | | — | | | 625 | |
Stock-based compensation expense | — | | | — | | | 7,894 | | | — | | | — | | | 7,894 | |
Other comprehensive income | — | | | — | | | — | | | 4,023 | | | — | | | 4,023 | |
Balance, March 31, 2021 | 70,824,745 | | | $ | 7 | | | $ | 479,017 | | | $ | (987) | | | $ | (182,477) | | | $ | 295,560 | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
APPIAN CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited, in thousands)
| | | | | | | | | | | |
| Three Months Ended March 31, |
| 2022 | | 2021 |
Cash flows from operating activities | | | |
Net loss | $ | (23,154) | | | $ | (13,587) | |
Adjustments to reconcile net loss to net cash used in operating activities | | | |
Depreciation and amortization | 1,773 | | | 1,278 | |
Bad debt expense | (2) | | | — | |
| | | |
Change in fair value of available-for-sale securities | 111 | | | (8) | |
Deferred income taxes | (1,073) | | | (448) | |
Stock-based compensation | 6,943 | | | 7,894 | |
Changes in assets and liabilities | | | |
Accounts receivable | 8,416 | | | 12,651 | |
Prepaid expenses and other assets | (3,579) | | | (279) | |
Deferred commissions | (1,383) | | | (2,642) | |
Accounts payable and accrued expenses | 2,338 | | | 1,159 | |
Accrued compensation and related benefits | (6,798) | | | (1,955) | |
Other current and non-current liabilities | 18 | | | 151 | |
Deferred revenue | (3,764) | | | (7,192) | |
Operating lease liabilities | (450) | | | 168 | |
Net cash used in operating activities | (20,604) | | | (2,810) | |
Cash flows from investing activities | | | |
Purchases of investments | (16,240) | | | — | |
Proceeds from investments | 21,729 | | | 5,625 | |
| | | |
Purchases of property and equipment | (3,390) | | | (468) | |
Net cash provided by investing activities | 2,099 | | | 5,157 | |
Cash flows from financing activities | | | |
Proceeds from exercise of common stock options | 24,404 | | | 625 | |
Net cash provided by financing activities | 24,404 | | | 625 | |
Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash | 40 | | | (682) | |
Net increase in cash, cash equivalents, and restricted cash | 5,939 | | | 2,290 | |
Cash, cash equivalents, and restricted cash at beginning of period | 103,960 | | | 112,462 | |
Cash, cash equivalents, and restricted cash at end of period | $ | 109,899 | | | $ | 114,752 | |
Supplemental disclosure of cash flow information | | | |
Cash paid for interest | $ | 78 | | | $ | 88 | |
Cash paid for income taxes | $ | 197 | | | $ | 148 | |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
APPIAN CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
1. Organization and Description of Business
Appian Corporation (together with its subsidiaries, “Appian,” the “Company,” “we,” or “our”) provides a low-code platform that accelerates the creation of high-impact business applications and workflows, enabling our customers to automate the most important aspects of their business. The Appian Low-Code Platform unifies the key capabilities needed to get work done faster: Process Mining + Workflow + Automation. Since 1999, industry leaders have trusted Appian and our open, enterprise-grade platform. Global organizations use our applications to improve customer experience, achieve operational excellence, and simplify global risk management and compliance.
We were incorporated in the state of Delaware in August 1999. We are headquartered in McLean, Virginia and operate in Canada, Switzerland, the United Kingdom, France, Germany, the Netherlands, Italy, Australia, Spain, Singapore, Sweden, and Japan.
2. Significant Accounting Policies
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements and footnotes have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) as contained in the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) for interim financial information. In the opinion of management, the interim financial information includes all adjustments of a normal recurring nature necessary for a fair presentation of the results of operations, financial position, changes in stockholders’ equity, and cash flows. The results of operations for the current period are not necessarily indicative of the results for the full year or the results for any future periods. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related footnotes included in our Annual Report on Form 10-K for the year ended December 31, 2021, filed with the Securities and Exchange Commission (the “SEC”) on February 17, 2022.
Use of Estimates
The preparation of our condensed consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and judgments that affect the amounts reported in these condensed consolidated financial statements and accompanying notes. Although we believe the estimates we use are reasonable, due to the inherent uncertainty involved in making these estimates, actual results reported in future periods could differ from those estimates.
Significant estimates embedded in the condensed consolidated financial statements include revenue recognition, income taxes and the related valuation allowance, the valuation of goodwill and intangible assets, leases, costs to obtain a contract with a customer, the valuation of financial instruments, and stock-based compensation.
The ongoing outbreak of the novel coronavirus disease (“COVID-19”) resulted in the declaration of a global pandemic and introduced a level of disruption and uncertainty into the financial markets and global economy. While the pandemic has been moving toward a controlled stage in the United States, we continue to monitor the developments surrounding the pandemic as of the date of issuance of these financial statements. We are not aware of any specific events or circumstances that would require us to update our estimates, assumptions, and judgments or revise the carrying value of our assets or liabilities. We cannot estimate the impacts COVID-19 may have on our business going forward as such impacts will be largely dependent upon a number of factors outside of our control including the extent and duration of the outbreak as well as any mitigating actions which may be undertaken by global governments and the general public.
Principles of Consolidation
The accompanying condensed consolidated financial statements include the accounts of Appian and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
APPIAN CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
Revenue Recognition
Refer to Note 3 for a detailed discussion on specific revenue recognition principles related to our major revenue streams.
Cost of Revenue
Subscriptions
Cost of subscriptions revenue consists primarily of fees paid to our third-party managed hosting providers and other third-party service providers, personnel costs such as payroll and benefits for our technology operations and customer support teams, and allocated facility costs and overhead.
Professional Services
Cost of professional services revenue includes all direct and indirect costs to deliver our professional services and training, including employee compensation for our global professional services and training personnel, third-party contractor costs, allocated facility costs and overhead, and the costs of billable expenses such as travel and lodging. The unpredictability of the timing of entering into significant professional services agreements sold on a standalone basis may cause significant fluctuations in our quarterly financial results and allocated facility costs and overhead.
Concentration of Credit and Customer Risk
Our financial instruments exposed to concentration of credit and customer risk consist primarily of cash, cash equivalents, restricted cash, accounts receivable, and our short- and long-term investments. Deposits held with banks may exceed the amount of insurance provided on such deposits; however, we believe the financial institutions holding our cash deposits are financially sound and, accordingly, minimal credit risk exists with respect to these balances.
With regard to our customers, credit evaluation and account monitoring procedures are used to minimize the risk of loss. We believe no additional credit risk beyond amounts provided for collection loss are inherent in accounts receivable. Revenue generated from government agencies represented 18.1% and 20.9% of our revenue for the three months ended March 31, 2022 and 2021, respectively, of which the top three U.S. federal government agencies generated 4.6% and 6.9% of our revenue for the three months ended March 31, 2022 and 2021, respectively. Additionally, 33.5% and 32.2% of our revenue during the three months ended March 31, 2022 and 2021, respectively, was generated from foreign customers.
Cash, Cash Equivalents, and Restricted Cash
We consider all highly liquid investments with an original or remaining maturity of three months or less at the date of purchase, as well as overnight repurchase agreements, to be cash equivalents. Restricted cash consists of cash designated to settle an escrow liability stemming from a holdback agreement enacted pursuant to our acquisition of Lana Labs GmbH (“Lana Labs”). The restriction on 25% of the balance will lapse on the later of either two months following the establishment of Lana Labs' annual financial statements for the year ended December 31, 2021 or October 31, 2022. The restrictions on the remaining 75% of the balance will lapse on August 11, 2023.
The following table presents a reconciliation of cash, cash equivalents, and restricted cash as presented in the condensed consolidated statements of cash flows (in thousands):
| | | | | | | | | | | |
| As of March 31, |
| 2022 | | 2021 |
Cash and cash equivalents | $ | 106,795 | | | $ | 114,752 | |
Restricted cash, current | 776 | | | — | |
Restricted cash, net of current portion | 2,328 | | | — | |
Total cash, cash equivalents, and restricted cash | $ | 109,899 | | | $ | 114,752 | |
APPIAN CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
Accounts Receivable and Allowance for Doubtful Accounts
Accounts receivable are stated at realizable value, net of an allowance for doubtful accounts. The allowance for doubtful accounts is based on our assessment of the collectability of accounts and incorporates an estimation of expected lifetime credit losses on our receivables. We regularly review the composition of the accounts receivable aging, historical bad debts, changes in payment patterns, customer creditworthiness, and current economic trends. If the financial condition of our customers were to deteriorate, resulting in their inability to make required payments, additional provisions for doubtful accounts would be required and would increase bad debt expense. There was an immaterial increase in the allowance for doubtful accounts from December 31, 2021 to March 31, 2022.
Assets Recognized from the Costs to Obtain a Contract with a Customer
We capitalize costs of obtaining a contract with a customer, including sales commissions paid to our direct sales team, that are incremental costs to obtaining customer contracts. These costs are recorded as deferred commissions in the condensed consolidated balance sheets. Costs to obtain a contract for a new customer or upsell are amortized over an estimated economic life of five years as sales commissions on initial sales are not commensurate with sales commissions on contract renewals. We determine the estimated economic life based on both qualitative and quantitative factors such as expected renewals, product life cycles, contractual terms, and customer attrition. We periodically review the carrying amount of deferred contract acquisition costs to determine whether events or changes in circumstances have occurred that could impact the estimated economic life. Commissions paid relating to contract renewals are deferred and amortized over the related renewal period. We also capitalize the incremental fringe benefits associated with commission expenses paid to our direct sales team. Costs to obtain a contract for professional services arrangements are expensed as incurred as the contractual period of our professional services arrangements are one year or less.
Amortization associated with deferred commission is recorded to sales and marketing costs in our condensed consolidated statements of operations. Commission expense was $8.2 million and $6.8 million for the three months ended March 31, 2022 and 2021, respectively.
Property and Equipment
Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. Significant additions or improvements extending the useful life of an asset are capitalized, while repairs and maintenance costs which do not significantly improve the related assets or extend their useful lives are charged to expense as incurred.
The following table outlines the useful lives of our major asset categories:
| | | | | | | | |
Asset Category | | Useful Life (in years) |
Computer software | | 3 |
Computer hardware | | 3 |
Equipment | | 5 |
Office furniture and fixtures | | 10 |
Leasehold improvements | | (a) |
(a) Leasehold improvements have an estimated useful life of the shorter of the useful life of the assets or the lease term.
Business Combinations
We account for business combinations using the acquisition method of accounting as of the business combination date. Under this method, we allocate the fair value of purchase consideration to identifiable tangible and intangible assets acquired and liabilities assumed at their estimated fair values on the acquisition date. The excess of the consideration transferred over the fair value of the identifiable net assets acquired is recorded as goodwill and represents the future economic benefits expected to arise from other intangible assets acquired that do not qualify for separate recognition, including assembled workforce, non-contractual relationships, and expected future synergies. Determining the fair value of assets acquired and liabilities assumed
APPIAN CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
requires us to use significant judgments and estimates, including the selection of valuation methodologies, estimates of future revenue, costs, and cash flows, and discount rates.
During the measurement period, which can be up to one year from the acquisition date, these estimates may be refined, as necessary, and we may record adjustments to the fair value of tangible and intangible assets acquired and liabilities assumed, with the corresponding offset to goodwill. Upon the conclusion of the measurement period or the final determination of the fair value of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our condensed consolidated statements of operations. Acquisition related expenses and post-acquisition integration costs are recognized separately from the business combination and are expensed as incurred.
Impairment of Goodwill and Long-Lived Assets
Long-lived assets and certain intangible assets are reviewed for impairment at least annually or more frequently whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable through undiscounted cash flows from the use of the assets. If such assets are considered to be impaired, the assets are written down to their estimated fair value.
With respect to goodwill, we have the option to qualitatively assess whether it is more likely than not the fair value of a reporting unit is less than its carrying value. If we elect to perform a qualitative assessment and conclude it is more likely than not the fair value of the reporting unit is equal to or greater than its carrying value, no further assessment of that reporting unit’s goodwill is necessary; otherwise, goodwill must be tested for impairment. Absent a specifically identified triggering event, we historically perform our annual assessment on the first day of the fourth quarter.
Because we operate under one reporting unit, the fair value of our reporting unit is based on our enterprise value. No indicators of impairment were identified for the three months ended March 31, 2022 or 2021.
Investments and Fair Value of Financial Instruments
Refer to Note 16 for a detailed discussion on our policies specific to investments and determining fair value.
Stock-Based Compensation
We account for stock-based compensation expense related to stock-based awards based on the estimated fair value of the award on the grant date. We calculate the fair value of stock options containing only a service condition using the Black-Scholes option pricing model. The fair value of restricted stock units (“RSUs”) is based on the closing market price of our common stock on the Nasdaq Global Market on the date of grant. For service-based awards such as RSUs, stock-based compensation expense is recognized on a straight-line basis over the requisite service period. For performance-based awards, stock-based compensation expense is recognized using the accelerated attribution method based on the probability of satisfying the performance condition. For awards that contain market conditions, compensation expense is measured using a Monte Carlo simulation and recognized using the accelerated attribution method over the derived service period based on the expected market performance as of the grant date. We account for forfeitures as they occur rather than estimating expected forfeitures.
Leases
Refer to Note 4 for a detailed discussion on our policies specific to leasing arrangements.
Recent Accounting Pronouncements
Adopted
In October 2021, the FASB issued Accounting Standard Update (“ASU”) 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which aims to improve the accounting for acquired revenue contracts with customers in a business combination. The ASU requires an entity (acquirer) to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. The guidance is effective for fiscal years beginning after December 15, 2022 and interim periods within those fiscal years. Early
APPIAN CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
adoption is permitted including in interim periods. The adoption of the new guidance did not have a material impact on our condensed consolidated financial statements.
3. Revenue
Revenue Recognition
We generate subscriptions revenue primarily through the sale of software as a service (“SaaS”) subscriptions bundled with maintenance and support and hosting services as well as term license subscriptions bundled with maintenance and support. We generate professional services revenue from fees for our consulting services, including application development and deployment assistance as well as training related to our platform.
The following table summarizes revenue from contracts with customers for the three months ended March 31, 2022 and 2021 (in thousands):
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
| 2022 | | 2021 | | | | |
SaaS subscriptions | $ | 53,379 | | | $ | 39,053 | | | | | |
Term license subscriptions | 24,707 | | | 19,853 | | | | | |
Maintenance and support | 5,634 | | | 4,860 | | | | | |
Total subscriptions | 83,720 | | | 63,766 | | | | | |
Professional services | 30,546 | | | 25,089 | | | | | |
Total revenue | $ | 114,266 | | | $ | 88,855 | | | | | |
Performance Obligations and Timing of Revenue Recognition
We primarily sell products and services that fall into the categories discussed below. Each category contains one or more performance obligations that are either (1) capable of being distinct (i.e., the customer can benefit from the product or service on its own or together with readily available resources, including those purchased separately from us) and distinct within the context of the contract (i.e., separately identified from other promises in the contract) or (2) a series of distinct products or services that are substantially the same and have the same pattern of transfer to the customer. Our term license subscriptions are delivered at a point in time while our SaaS subscriptions, maintenance and support, and professional services are delivered over time.
Subscriptions Revenue
Subscriptions revenue is primarily related to (1) SaaS subscriptions bundled with maintenance and support and hosting services and (2) term license subscriptions bundled with maintenance and support. We generally charge subscription fees on a per-user basis or through non-user based single application licenses. We bill customers and collect payment for subscriptions to our platform in advance on an annual, quarterly, or monthly basis. In certain instances, our customers have paid their entire contract up front.
SaaS Subscriptions
We generate cloud-based subscriptions revenue primarily from the sales of subscriptions to access our cloud offering, together with related support services to our customers. We perform all required maintenance and support for our cloud offering. Revenue is recognized on a ratable basis over the contract term beginning on the date the service is made available to the customer. Our cloud-based subscription contracts generally have a term of one to three years in length. We bill customers and collect payment for subscriptions to our platform in advance, and they are non-cancellable.
Term License Subscriptions
APPIAN CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
Our term license subscription revenue is derived from customers with on-premises installations of our platform pursuant to contracts that were historically one to three years in length. The majority of recent contracts have been one year in length. Although term license subscriptions are sold with maintenance and support, the software is fully functional at the beginning of the subscription and is considered a distinct performance obligation. On rare occasions, a cloud-based subscription may include the right for the customer to take possession of the license and as such, the revenue is treated as a license. Revenue from term license subscriptions is recognized when control of the software license has transferred to the customer, which is the later of delivery or commencement of the contract term.
Maintenance and Support
Maintenance and support subscriptions include both technical support and when-and-if-available software upgrades, which are treated as a single performance obligation as they are considered a series of distinct services that are substantially the same and have the same duration and measure of progress. Revenue from maintenance and support is recognized ratably over the contract period, which is the period over which the customer has continuous access to maintenance and support.
Professional Services Revenue
Our professional services revenue is comprised of fees for consulting services, including application development and deployment assistance as well as training services related to our platform. Our professional services are considered distinct performance obligations when sold standalone or with other products.
Consulting Services
We sell consulting services to assist customers in planning and executing the deployment of our software. Customers are not required to use consulting services to fully benefit from the software. Consulting services are regularly sold on a standalone basis and either (1) under a fixed-fee arrangement or (2) on a time and materials basis. Consulting contracts are each considered separate performance obligations because they do not integrate with each other or with other products and services to deliver a combined output to the customer, do not modify or customize (or are not modified or customized by) each other or other products and services, and do not affect the customer's ability to use the other consulting offerings or other products and services. Revenue under consulting contracts is recognized over time as services are delivered. For time and materials-based consulting contracts, we have elected the practical expedient of recognizing revenue upon invoicing since the invoiced amount corresponds directly to the value of our service to date.
Training Services
We sell various training services to our customers. Training services are sold in the form of prepaid training credits that are redeemed based on a fixed rate per course. Training revenue is recognized when the associated training services are delivered.
Significant Judgments and Estimates
Determining the Transaction Price
The transaction price includes both fixed and variable consideration. Variable consideration is included in the transaction price to the extent it is probable a significant reversal will not occur. The amount of variable consideration excluded from the transaction price for the three months ended March 31, 2022 and 2021 was insignificant. Our estimates of variable consideration are also subject to subsequent true-up adjustments and may result in changes to transaction prices; however, such true-up adjustments are not expected to be material.
Allocating the Transaction Price Based on Standalone Selling Prices (“SSP”)
We allocate the transaction price to each performance obligation in a contract based on its relative SSP. The SSP is the observable price at which we sell the product or service separately. In the absence of observable pricing, we estimate SSP using the residual approach. We establish SSP as follows:
APPIAN CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
1.SaaS subscriptions - Given the highly variable selling price of our SaaS subscriptions, we establish the SSP of our SaaS subscriptions using a residual approach after first determining the SSP of consulting and training services. We have concluded the residual approach to estimating SSP of our SaaS subscriptions is an appropriate allocation of the transaction price.
2.Term license subscriptions - Given the highly variable selling price of our term license subscriptions, we have established SSP of term license subscriptions using a residual approach after first determining the SSP of maintenance and support. Maintenance and support is sold on a standalone basis in conjunction with renewals of our legacy perpetual software licenses and within a narrow range of the net license fee. Because an economic relationship exists between the license and maintenance and support, we have concluded the residual approach to estimating SSP of term license subscriptions is an appropriate allocation of the transaction price.
3.Maintenance and support - We establish the SSP of maintenance and support as a percentage of the stated net subscription fee based on observable pricing of maintenance and support renewals from our legacy perpetual software licenses.
4.Consulting and training services - The SSP of consulting and training services is established based on the observable pricing of standalone sales within each geographic region where the services are sold.
Contract Balances
Timing may differ between the satisfaction of performance obligations and the invoicing and collection of amounts related to our contracts with customers. Contract assets primarily relate to unbilled amounts for contracts with customers for which the amount of revenue recognized exceeds the amount billed to the customer. Contract assets are transferred to accounts receivable when the right to invoice becomes unconditional. As of March 31, 2022 and December 31, 2021, contract assets of $15.6 million and $14.0 million, respectively, are included in the Prepaid expenses and other current assets and Other assets line items in our condensed consolidated balance sheets.
Contract liabilities consist of deferred revenue and include payments received in advance of the satisfaction of performance obligations. Deferred revenue is then recognized as the revenue recognition criteria are met. Deferred revenue that will be recognized during the succeeding 12-month period is recorded as current, and the remaining deferred revenue is recorded as non-current. For the three months ended March 31, 2022, we recognized $65.7 million of revenue that was included in the deferred revenue balance as of December 31, 2021.
Transaction Price Allocated to the Remaining Performance Obligations
As of March 31, 2022, we had an aggregate transaction price of $290.8 million allocated to unsatisfied performance obligations. We expect to recognize $186.0 million of this balance as revenue over the next 12 months with the remaining amount recognized thereafter.
4. Leases
As of March 31, 2022, we have operating leases for corporate offices. Our operating leases have remaining lease terms of roughly 1 year to 10 years, some of which include options to extend the leases for up to an additional 10 years.
Right-of-Use (“ROU”) Assets and Lease Liabilities
At the inception of an arrangement, we determine whether the arrangement is or contains a lease based on the unique facts and circumstances present and the classification of the lease. Operating leases with a term greater than one year are recognized on the balance sheet as ROU assets, lease liabilities, and, if applicable, long-term lease liabilities. ROU assets represent our right to use an underlying asset for the lease term, and lease liabilities represent our obligation to make lease payments arising from the lease. We have elected not to recognize on our condensed consolidated balance sheets leases with a term of one year or less. For contracts with lease and non-lease components, we have elected not to allocate the contract consideration but rather to account for the lease and non-lease components as a single lease component.
APPIAN CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
Lease liabilities and their corresponding ROU assets are recorded based on the present value of lease payments over the expected lease term. The implicit rates within most of our leases are generally not determinable; therefore, we use the incremental borrowing rate at the lease commencement date to determine the present value of lease payments. The determination of our incremental borrowing rate requires judgment and is estimated for each lease based on the rate we would have to pay for a collateralized loan with the same term and payments as the lease. We consider various factors, including our level of collateralization, estimated credit rating, and the currency in which the lease is denominated. Operating lease ROU assets also include any lease prepayments, offset by lease incentives. Certain of our leases include options to extend or terminate the lease. An option to extend the lease is considered in connection with determining the ROU asset and lease liability when it is reasonably certain we will exercise that option while an option to terminate is considered unless it is reasonably certain we will not exercise the option. For certain equipment leases, we apply a portfolio approach to effectively account for the operating lease ROU assets and liabilities.
Headquarters Lease
In April 2018, we entered into a lease agreement with respect to 176,222 square feet of office space in McLean, Virginia for a new corporate headquarters. The initial term of the lease was 150 months. We took initial possession of the first phase of the new headquarters in October 2018 and began to recognize rent expense as of that date. In February 2019, we took possession of an additional 28,805 square feet of adjacent office space.
In January 2020, we entered into an amendment which adjusted the original terms of the headquarters lease. Under this amendment, we exercised an option to expand occupancy, adding 34,158 square feet of office space. Occupancy of the added space commenced on October 14, 2020. Pursuant to the guidance of ASC 842, Leases, the amendment is considered a modification to the original lease and is accounted for as a separate contract because it represents a new ROU asset and the lease costs on the new space are charged at prevailing market rates. Effective July 1, 2020, we took possession of the space, began to recognize rent expense, and recorded a $7.9 million ROU asset and lease liability on our condensed consolidated balance sheets.
In November 2021, we entered into a third amendment to our headquarters lease, in which we exercised an option to expand occupancy into two adjacent office spaces of 32,883 and 25,925 square feet, with occupancy to commence on September 1, 2022 and May 1, 2023, respectively. Concurrent with the amendment, we also entered into a sublease agreement in which we agreed to sublease 32,883 square feet of space effective September 1, 2022. The sublease terminates on August 31, 2025 but may be extended one additional year at the sublessee’s option. The amendment is considered a modification to the original lease and each space is accounted for as a separate contract because it represents a new ROU asset and the lease costs charged on the new spaces are at prevailing market rates. As of March 31, 2022, we have not taken possession of either space nor met the criteria for the leases and sublease to be considered commenced. Accordingly, we have not reported an ROU asset or liability on our condensed consolidated balance sheets nor have recorded expense or sublease income on our condensed consolidated statements of operations in relation to the additional spaces.
Lease Costs
Expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as depreciation expense and interest expense. We have lease agreements which require payments for lease and non-lease components (i.e., common area maintenance) that are accounted for as a single lease component. Variable lease payment amounts that cannot be determined at the commencement of the lease, such as maintenance costs based on future obligations, are not included in ROU assets or lease liabilities but rather are expensed as incurred and recorded as variable lease expense.
APPIAN CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
The following table sets forth the components of lease expense for the three months ended March 31, 2022 and 2021 (in thousands):
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
| 2022 | | 2021 | | | | |
Operating lease cost | $ | 1,634 | | | $ | 1,630 | | | | | |
Short-term lease cost | 88 | | | 41 | | | | | |
Variable lease cost | 973 | | | 25 | | | | | |
Total | $ | 2,695 | | | $ | 1,696 | | | | | |
Supplemental Lease Information
Supplemental balance sheet information related to operating leases as of March 31, 2022 and December 31, 2021 was as follows (in thousands, except for lease term and discount rate):
| | | | | | | | | | | |
| As of |
| March 31, 2022 | | December 31, 2021 |
Operating right-of-use assets | $ | 27,556 | | $ | 27,897 |
| | | |
Operating lease liabilities, current | $ | 8,135 | | $ | 8,110 |
Operating lease liabilities, net of current portion | 47,964 | | 48,784 |
Total operating lease liabilities | $ | 56,099 | | $ | 56,894 |
| | | |
Weighted average remaining lease term (in years) | 9.3 | | 9.5 |
| | | |
Weighted average discount rate | 9.5 | % | | 9.5 | % |
Supplemental cash flow and expense information related to operating leases for the three months ended March 31, 2022 and 2021 was as follows (in thousands):
| | | | | | | | | | | |
| Three Months Ended March 31, |
| 2022 | | 2021 |
Operating cash outflows for operating leases | $ | 2,085 | | | $ | 1,749 | |
| | | |
Amortization of operating ROU assets | 306 | | | 324 | |
Interest expense on operating lease liabilities | 1,321 | | | 402 | |
APPIAN CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
A summary of our future minimum lease commitments under non-cancellable leases as of March 31, 2022 is as follows (in thousands):
| | | | | |
| Operating Leases |
2022 (excluding the three months ended March 31, 2022) | $ | 6,361 | |
2023 | 8,303 | |
2024 | 8,619 | |
2025 | 9,316 | |
2026 | 9,363 | |
| |
Thereafter | 48,775 | |
Total lease payments | 90,737 | |
Less: imputed interest | (34,638) | |
Total | $ | 56,099 | |
5. Business Combinations
In August 2021, we acquired 100% of the outstanding common stock of Lana Labs, a developer of process mining software, for approximately $30.7 million, net of cash acquired and debt. The acquisition was made due to the attractive nature of the product offerings of Lana Labs and in furtherance of our objective to enhance our automation platform. The transaction was financed through available cash on hand.
The allocation of the purchase price is preliminary pending the finalization of the fair value of the acquired net assets, liabilities assumed, deferred income taxes, and assumed income and non-income based tax liabilities. As of the acquisition date, the purchase price was assigned to the acquired assets and assumed liabilities as follows (in thousands):
| | | | | |
Cash acquired | $ | 256 | |
Other current assets | 106 | |
Property and equipment | 59 | |
Developed technology | 5,974 | |
Customer relationships | 750 | |
Goodwill | 24,521 | |
Other non-current assets | 27 | |
Total assets acquired | 31,693 | |
Current liabilities | 638 | |
Non-current liabilities | 38 | |
Total liabilities assumed | 676 | |
Net assets acquired | $ | 31,017 | |
There were no changes to our reportable segments as a result of the acquisition, and acquisition costs incurred in relation to the transaction were immaterial. We do not expect the purchase price allocated to goodwill and intangible assets to be deductible for tax purposes.
Since the acquisition date, measurement period adjustments have included a $0.8 million adjustment to developed technology and goodwill related to an update to the discount rate utilized in our valuation of intangibles, a $0.3 million increase in deferred revenue stemming from our early adoption of new accounting guidance surrounding deferred revenue recognized pursuant to a business combination, a $0.1 million deferred tax adjustment, and an immaterial adjustment to working capital. No additional measurement period adjustments were recognized for the three months ended March 31, 2022.
APPIAN CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
6. Goodwill and Intangible Assets
Goodwill was comprised of the following as of March 31, 2022 and December 31, 2021 (in thousands):
| | | | | |
| Carrying Amount |
Balance as of December 31, 2020 | $ | 4,862 | |
Goodwill acquired | 24,521 | |
Foreign currency translation adjustments | (1,588) | |
Balance as of December 31, 2021 | 27,795 | |
Goodwill acquired | — | |
Foreign currency translation adjustments | (524) | |
Balance as of March 31, 2022 | $ | 27,271 | |
Intangible assets, net consisted of the following as of March 31, 2022 and December 31, 2021 (in thousands):
| | | | | | | | | | | |
| As of |
| March 31, 2022 | | December 31, 2021 |
Developed technology | $ | 7,133 | | | $ | 7,271 | |
Customer relationships - Non-Robotic Process Automation (“RPA”) | 856 | | | 872 | |
Customer relationships - RPA | 256 | | | 261 | |
Intangible assets, gross | 8,245 | | | 8,404 | |
Less: accumulated amortization | (1,630) | | | (1,260) | |
Intangible assets, net | $ | 6,615 | | | $ | 7,144 | |
Intangible amortization expense was $0.4 million and $0.1 million for the three months ended March 31, 2022 and 2021, respectively. As of March 31, 2022, the weighted average remaining amortization periods for developed technology, non-RPA customer relationships, and RPA customer relationships were approximately 4.2 years, 8.9 years, and 7.8 years, respectively.
The projected annual amortization expense related to amortizable intangible assets as of March 31, 2022 is as follows (in thousands):
| | | | | |
| Projected Amortization |
2022 (excluding the three months ended March 31, 2022) | $ | 1,181 | |
2023 | 1,522 | |
2024 | 1,522 | |
2025 | 1,211 | |
2026 | 779 | |
Thereafter | 400 | |
Total projected amortization expense | $ | 6,615 | |
APPIAN CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
7. Property and Equipment, net
Property and equipment, net consisted of the following as of March 31, 2022 and December 31, 2021 (in thousands):
| | | | | | | | | | | |
| March 31, 2022 | | December 31, 2021 |
Leasehold improvements | $ | 42,630 | | | $ | 41,005 | |
Office furniture and fixtures | 3,259 | | | 2,536 | |
Computer hardware | 6,577 | | | 6,001 | |
Computer software | 1,354 | | | 1,353 | |
Equipment | 179 | | | 124 | |
Property and equipment, gross | 53,999 | | | 51,019 | |
Less: accumulated depreciation | (15,473) | | | (14,106) | |
Property and equipment, net | $ | 38,526 | | | $ | 36,913 | |
Depreciation expense totaled $1.4 million and $1.2 million for the three months ended March 31, 2022 and 2021, respectively. We had no disposals or retirements and recorded no gains or losses on disposal during each of the three months ended March 31, 2022 and 2021.
8. Accrued Expenses
Accrued expenses consisted of the following as of March 31, 2022 and December 31, 2021 (in thousands):
| | | | | | | | | | | |
| March 31, 2022 | | December 31, 2021 |
Accrued hosting costs | $ | 3,044 | | | $ | 1,995 | |
Accrued legal costs | 7,899 | | | 5,511 | |
Accrued marketing and tradeshow expenses | 1,019 | | | 1,167 | |
Accrued third party license fees | 1,283 | | | 1,066 | |
Accrued contract labor costs | 1,299 | | | 891 | |
Accrued reimbursable employee expenses | 1,023 | | | 870 | |
Accrued taxes payable | 732 | | | 550 | |
Accrued audit and tax expenses | 504 | | | 439 | |
Accrued capital expenditures | — | | | 379 | |
Other accrued expenses | 1,851 | | | 2,615 | |
Total | $ | 18,654 | | | $ | 15,483 | |
9. Debt
Line of Credit
In November 2017, we entered into a $20.0 million revolving line of credit with a lender. In December 2021, we executed the first loan modification agreement which extended the revolving line of credit's maturity date from November 2022 to November 2025 and amended certain borrowing terms and financial covenants, and in January 2022, we executed the second loan modification agreement to increase the aggregate amount of funds our foreign subsidiaries are allowed to maintain outside of the United States.
Under the amended agreement, we may elect whether amounts drawn on the revolving line of credit bear interest on the outstanding principal amount at a rate per annum equal to either a) the Prime rate plus an additional interest rate margin or b) the secured overnight financing rate (“SOFR”) plus an additional interest rate margin that is determined by the availability of the borrowings under the revolving line of credit. The additional interest rate margin will range from 0.75% to 1.25% in the
APPIAN CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
case of Prime rate advances and from 1.75% to 2.25% in the case of SOFR advances. The revolving line of credit contains an unused facility fee up to 0.20% of the average unused portion of the revolving line of credit, which is payable quarterly. The agreement contains certain customary affirmative and negative covenants and requires us to maintain (i) an adjusted quick ratio of at least 1.35 to 1.00 subject to a net cash threshold as set forth in the agreement and (ii) minimum adjusted EBITDA, in the amounts and for the periods set forth in the agreement. Any amounts borrowed under the credit facility are collateralized by substantially all of our assets. We were in compliance with all covenants as of March 31, 2022. As of March 31, 2022, we had no outstanding borrowings under this revolving line of credit, and we had outstanding letters of credit totaling $11.2 million in connection with securing our leased office space.
10. Income Taxes
The provision for income taxes is based upon the estimated annual effective tax rates for the year applied to the current period income before tax plus the tax effect of any significant or unusual items, discrete events, or changes in tax law. Our operating subsidiaries are exposed to statutory effective tax rates ranging from zero to approximately 35%. Fluctuations in the distribution of pre-tax income among our operating subsidiaries can lead to fluctuations of the effective tax rate in the condensed consolidated financial statements. For the three months ended March 31, 2022 and 2021, the actual effective tax rates were 6.4% and (0.9)%, respectively. The year to date tax benefit for the three months ended March 31, 2022 was primarily driven by a discrete benefit of $1.1 million related to the release of a valuation allowance for Lana Labs as a result of post-integration tax planning and the merger of German subsidiaries.
We assess uncertain tax positions in accordance with ASC 740-10, Accounting for Uncertainties in Income Taxes. As of March 31, 2022, our net unrecognized tax benefits totaled $3.1 million, which if recognized would result in no net effect on the effective tax rate due to a valuation allowance. The amount of reasonably possible unrecognized tax benefits that could decrease over the next 12 months due to the expiration of certain statutes of limitations or settlements of tax audits is not material to our condensed consolidated financial statements.
We file income tax returns in the U.S. federal jurisdiction and in various state and foreign jurisdictions. Due to our net operating loss (“NOL”) carryforward, the tax years 2016 through 2021 remain open to examination by the major taxing jurisdictions to which we are subject. There are no open examinations that would have a meaningful impact to our condensed consolidated financial statements.
11. Stock-Based Compensation
Equity Incentive Plans
In May 2017, our Board of Directors adopted, and our stockholders approved, the 2017 Equity Incentive Plan (the “2017 Plan”), which became effective as of the date of the final prospectus for our initial public offering. The 2017 Plan provides for the grant of incentive stock options to employees and for the grant of nonstatutory stock options, restricted stock awards, RSUs, stock appreciation rights, performance-based stock awards, and other forms of equity compensation to employees, including officers, non-employee directors, and consultants. We initially reserved 6,421,442 shares of Class A common stock for issuance under the 2017 Plan, which included 421,442 shares that remained available for issuance under our 2007 Stock Option Plan (the “2007 Plan”) at the time the 2017 Plan became effective. The number of shares reserved under the 2017 Plan increases for any shares subject to outstanding awards originally granted under the 2007 Plan that expire or are forfeited prior to exercise. As a result of the adoption of the 2017 Plan, no further grants may be made under the 2007 Plan. As of March 31, 2022, there were 7,186,749 shares of Class A common stock reserved for issuance under the 2017 Plan, of which 3,749,501 were available to be issued.
Stock Options
We estimate the fair value of stock options containing only a service condition using the Black-Scholes option pricing model, which requires the use of subjective assumptions, including the expected term of the option, the current price of the underlying stock, the expected stock price volatility, expected dividend yield, and the risk-free interest rate for the expected term of the option. The expected term represents the period of time the stock options are expected to be outstanding. Due to the lack of sufficient historical exercise data to provide a reasonable basis upon which to otherwise estimate the expected term of the stock options, we use the simplified method to estimate the expected term for our stock options. Under the simplified
APPIAN CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
method, the expected term of an option is presumed to be the mid-point between the vesting date and the end of the contractual term. Expected volatility is based on historical volatilities for publicly traded stock of comparable companies over the estimated expected term of the stock options. We assume no dividend yield because dividends are not expected to be paid in the near future, which is consistent with our history of not paying dividends.
In May 2019, our Board of Directors granted a stock option to purchase 700,000 shares of our Class A common stock to our Chief Executive Officer (the “2019 CEO Grant”) under the 2017 Plan with an exercise price of $33.98 per share. The 2019 CEO Grant is eligible to vest based on the achievement of a stock price appreciation target of our Class A common stock. Specifically, the 2019 CEO Grant vests when shares of our Class A common stock close at or above $84.63 per share for a period equal to or greater than 90 consecutive calendar days or upon the occurrence of a change in control in which the value of our Class A common stock is equal to or greater than $84.63 per share within five years of the grant date. The fair value of the 2019 CEO Grant was determined using a Monte Carlo simulation. The fair value of the award at the grant date was $9.5 million and was amortized over the derived service period of 2.6 years. In February 2021, the 2019 CEO Grant satisfied all of the conditions required to be considered fully vested and as a result, we accelerated the recognition of approximately $3.3 million in stock-based compensation expense in the three months ended March 31, 2021.
The following table summarizes stock option activity for the three months ended March 31, 2022:
| | | | | | | | | | | | | | | | | | | | | | | |
| Number of Shares | | Weighted Average Exercise Price | | Weighted Average Remaining Contractual Term (Years) | | Aggregate Intrinsic Value (in thousands) |
Outstanding at January 1, 2022 | 2,953,356 | | | $ | 15.16 | | | 4.0 | | $ | 147,812 | |
Granted | — | | | — | | | — | | | — | |
Exercised | (815,833) | | | 29.91 | | | — | | | 28,281 | |
Expired | (580) | | | 9.81 | | | — | | | — | |
Forfeited | (8,000) | | | 12.10 | | | — | | | — | |
Outstanding at March 31, 2022 | 2,128,943 | | | $ | 9.52 | | | 4.3 | | $ | 109,212 | |
| | | | | | | |
Exercisable at March 31, 2022 | 1,996,823 | | | $ | 9.35 | | | 4.2 | | $ | 102,776 | |
There were no stock options granted during the three months ended March 31, 2022 and 2021. The total fair value of stock options that vested during the three months ended March 31, 2022 and 2021 was $0.2 million and $9.7 million, respectively. As of March 31, 2022, the total compensation cost related to unvested stock options not yet recognized was nominal and will be recognized over a weighted average period of 0.2 years.
Restricted Stock Units
The following table summarizes RSU activity for the three months ended March 31, 2022:
| | | | | | | | | | | |
| Number of Shares | | Weighted Average Grant Date Fair Value |
Non-vested and outstanding at January 1, 2022 | 1,209,529 | | | $ | 70.99 | |
Granted | 222,599 | | | 57.16 | |
Vested | (47,038) | | | 69.01 | |
Forfeited | (45,053) | | | 68.09 | |
Non-vested and outstanding at March 31, 2022 | 1,340,037 | | | 68.86 | |
As of March 31, 2022, total unrecognized compensation cost related to unvested RSUs was approximately $79.1 million, which will be recognized over a weighted average period of 1.9 years.
APPIAN CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
The following table summarizes the components of our stock-based compensation expense by instrument type for the three months ended March 31, 2022 and 2021 (in thousands):
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
| 2022 | | 2021 | | | | |
RSUs | $ | 6,786 | | | $ | 4,005 | | | | | |
Stock options | 1 | | | 3,733 | | | | | |
Common stock awards to Board of Directors | 156 | | | 156 | | | | | |
Total stock-based compensation expense | $ | 6,943 | | | $ | 7,894 | | | | | |
Stock-based compensation expense for RSUs, stock options, and issuances of common stock to the Board of Directors is included in the following line items in the accompanying condensed consolidated statements of operations for the three months ended March 31, 2022 and 2021 (in thousands):
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
| 2022 | | 2021 | | | | |
Cost of revenue | | | | | | | |
Subscriptions | $ | 179 | | | $ | 297 | | | | | |
Professional services | 1,057 | | | 641 | | | | | |
Operating expenses | | | | | | | |
Sales and marketing | 1,788 | | | 1,108 | | | | | |
Research and development | 2,314 | | | 1,015 | | | | | |
General and administrative | 1,605 | | | 4,833 | | | | | |
Total stock-based compensation expense | $ | 6,943 | | | $ | 7,894 | | | | | |
12. Stockholders' Equity
As of March 31, 2022, we had authorized 500,000,000 shares of Class A common stock and 100,000,000 shares of Class B common stock, each with a par value of $0.0001 per share, of which 40,829,564 shares of Class A common stock and 31,497,796 shares of Class B common stock were issued and outstanding. The rights of the holders of Class A common stock and Class B common stock are identical, except with respect to voting and conversion rights. The holders of Class A common stock are entitled to one vote per share, and the holders of Class B common stock are entitled to ten votes per share on all matters subject to stockholder vote. The holders of Class B common stock also have approval rights for certain corporate actions. Each share of Class B common stock may be converted into one share of Class A common stock at the option of its holder and will be automatically converted upon transfer thereof, subject to certain exceptions. In addition, upon the date on which the outstanding shares of Class B common stock represent less than 10% of the aggregate voting power of our capital stock, all outstanding shares of Class B common stock shall convert automatically into Class A common stock.
13. Basic and Diluted Loss per Common Share
The following outstanding securities, prior to the use of the treasury stock method or the if-converted method, have been excluded from the computation of diluted weighted-average shares outstanding for the respective periods below because they would have been antidilutive:
| | | | | | | | | | | |
| Three Months Ended March 31, |
| 2022 | | 2021 |
Stock options | 2,128,943 | | | 3,309,771 | |
Non-vested restricted stock units | 1,340,037 | | | 1,125,631 | |
APPIAN CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
14. Commitments and Contingencies
Contractual Warranty and Indemnification Obligations
We provide limited product warranties. Historically, any payments made under these provisions have been immaterial. We also agree to standard indemnification provisions in the ordinary course of business. Pursuant to these provisions, we agree to indemnify, hold harmless, and reimburse the indemnified party for losses suffered or incurred by the indemnified party, generally our customers, in connection with certain intellectual property infringement claims by any third party arising from the use of our products or services in accordance with the agreement. The term of our contractual indemnity provisions often survives termination or expiration of the applicable agreement. We carry insurance that covers certain third-party claims relating to our services and limits our exposure. We have never incurred costs to defend lawsuits or settle claims related to these indemnification provisions.
Minimum Purchase Commitments
In July 2021, we executed a non-cancellable cloud hosting arrangement with Amazon Web Services (“AWS”) that contains provisions for minimum purchase commitments. Specifically, purchase commitments under the agreement total $131.0 million over five years, including $22.0 million in the first year, $25.0 million in the second year, and $28.0 million in each of the third, fourth, and fifth years. The timing of payments under the agreement may vary, and the total amount of payments may exceed the minimum depending on the volume of services utilized. Spending under this agreement for the three months ended March 31, 2022 totaled $7.8 million.
Exclusive of the AWS contract, we have other non-cancellable agreements for subscription software products that contain provisions stipulating minimum purchase commitments. However, the annual purchase commitments under these contracts are, individually and in the aggregate, immaterial to our condensed consolidated financial statements.
Letters of Credit
At each of March 31, 2022 and December 31, 2021, we had outstanding letters of credit totaling $11.2 million in connection with securing our leased office space. All letters of credit are secured by our borrowing arrangement as described in Note 9.
Legal
From time to time, we are subject to legal, regulatory, and other proceedings and claims that arise in the ordinary course of business. There are no issues or resolutions of any matters expected to have a material adverse impact on our condensed consolidated financial statements.
APPIAN CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
15. Segment and Geographic Information
We consider operating segments to be components of our business in which separate financial information is available and evaluated regularly by our Chief Operating Decision Maker (“CODM”). Our CODM, who is our Chief Executive Officer, reviews financial information on a consolidated basis when deciding how to allocate resources and assessing performance. Accordingly, we have determined we have a single reporting segment and operating unit structure.
The following table summarizes revenue by geography for the three months ended March 31, 2022 and 2021 (in thousands):
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
| 2022 | | 2021 | | | | |
Domestic | $ | 76,039 | | | $ | 60,282 | | | | | |
International | 38,227 | | | 28,573 | | | | | |
Total | $ | 114,266 | | | $ | 88,855 | | | | | |
With respect to geographic information, revenue is attributed to respective geographies based on the contracting address of the customer. There were no individual foreign countries from which more than 10% of our total revenue was attributable for the three months ended March 31, 2022 or 2021. Substantially all of our long-lived assets were held in the United States as of March 31, 2022 and December 31, 2021.
16. Investments and Fair Value Measurements
Fair Value Measurements
We use a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires us to use observable inputs when available and to minimize the use of unobservable inputs when determining fair value. The three tiers are defined as follows:
•Level 1. Observable inputs based on unadjusted quoted prices in active markets for identical assets or liabilities;
•Level 2. Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and
•Level 3. Unobservable inputs for which there is little or no market data, which require us to develop our own assumptions.
The asset or liability’s fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques maximize the use of relevant observable inputs and minimize the use of unobservable inputs. There were no instruments measured at fair value on a recurring basis using significant unobservable inputs as of March 31, 2022 and December 31, 2021.
The valuation techniques that may be used to measure fair value are as follows:
•Market approach - Uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities;
•Income approach - Uses valuation techniques to convert future amounts to a single present amount based on current market expectations about those future amounts;
•Cost approach - Based on the amount that currently would be required to replace the service capacity of an asset (i.e., replacement cost).
APPIAN CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
The carrying amounts of our cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses approximate fair value as of March 31, 2022 and December 31, 2021 because of the relatively short duration of these instruments.
Investments
Our investment portfolio consists largely of debt investments classified as available-for-sale. Changes in the fair value of available-for-sale securities, excluding other-than-temporary impairments, are recorded in other comprehensive income (loss). The components of our investments as of March 31, 2022 are as follows (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| As of March 31, 2022 |
| Fair Value Measurement | | Balance Sheet Classification |
| Fair Value Level | | Cost Basis | | Unrealized Gains (Losses) | | Market Value | | Cash and Cash Equivalents | | Short-term Investments and Marketable Securities | | Long-term Investments |
Money market fund | Level 1 | | $ | 43,555 | | | $ | — | | | $ | 43,555 | | | $ | 43,555 | | | $ | — | | | $ | — | |
U.S. Treasuries | Level 1 | | 7,003 | | | (3) | | | 7,000 | | | — | | | 7,000 | | | — | |
Commercial paper | Level 2 | | 23,110 | | | — | | | 23,110 | | | — | | | 23,110 | | | — | |
Corporate bonds | Level 2 | | 26,148 | | | (114) | | | 26,034 | | | — | | | 17,850 | | | 8,184 | |
Asset-backed securities | Level 2 | | 5,493 | | | (15) | | | 5,478 | | | — | | | 5,478 | | | — | |
Total investments | | | $ | 105,309 | | | $ | (132) | | | $ | 105,177 | | | $ | 43,555 | | | $ | 53,438 | | | $ | 8,184 | |
At December 31, 2021, our investments consisted of the following (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| As of December 31, 2021 |
| Fair Value Measurement | | Balance Sheet Classification |
| Fair Value Level | | Cost Basis | | Unrealized Gains (Losses) | | Market Value | | Cash and Cash Equivalents | | Short-term Investments and Marketable Securities | | Long-term Investments |
Money market fund | Level 1 | | $ | 38,301 | | | $ | — | | | $ | 38,301 | | | $ | 38,301 | | | $ | — | | | $ | — | |
U.S. Treasury bonds | Level 1 | | 8,171 | | | — | | | 8,171 | | | — | | | 8,171 | | | — | |
Commercial paper | Level 2 | | 23,312 | | | — | | | 23,312 | | | — | | | 23,312 | | | — | |
Corporate bonds | Level 2 | | |